BioCentury | Jan 25, 2016
Company News

Takara Bio sales and marketing update

...Takara’s Clontech Laboratories Inc. subsidiary launched the Guide-it CRISPR/ Cas9 Gesicle production system for the delivery of Cas9...
BioCentury | Nov 24, 2014
Company News

Broad Institute, Takara Bio deal

...Takara’s Clontech Laboratories Inc. subsidiary received non-exclusive rights to Broad’s IP related to CRISPR/ Cas9 gene editing system...
BioCentury | Apr 25, 2011
Company News

Ariad, Takara Bio sales and marketing update

...Takara Bio's Clontech Laboratories Inc. subsidiary launched iDimerize inducible dimerization systems in the U.S. for research use only...
...cell and gene therapy. The systems use Ariad's Argent cell signaling regulation technology, for which Clontech...
BioCentury | Aug 2, 2010
Company News

Gentel sales and marketing update

...The kit combine Gentel's APiX chromogenic detection platform and Antibody 380 array technology from the Clontech Laboratories Inc....
BioCentury | Aug 2, 2010
Company News

Takara Bio, TET Systems GmbH & Co. KG deal

...Takara's Clontech Laboratories Inc. subsidiary and TET added the Tet-On 3G System to a 1996 deal, granting Clontech...
...system is a research tool designed to control gene expression in vitro and in vivo. Clontech...
BioCentury | Jun 4, 2007
Company News

Invitrogen, Takara Bio supply/service news

...Takara's Clontech Laboratories Inc. subsidiary and IVGN settled all litigation related to IVGN's patents covering RNase H minus...
...covering RNase H minus reverse transcriptase. The RNA-dependent DNA polymerase is used in cDNA synthesis. Clontech...
...last of the patents expires in 2012. Further terms were not disclosed. IVGN originally accused Clontech...
BioCentury | Jul 31, 2006
Company News

Takara Bio, Bayer sales and marketing update

...BAY's Bayer Healthcare unit granted Takara's Clontech division an exclusive worldwide license to sell Ready-to-Glow secreted...
BioCentury | Oct 11, 2004
Company News

Becton Dickinson supply/service news

...BDX plans to sell its Clontech division in order to focus on cell analysis products, discovery...
...order to focus on cell analysis products, discovery labware, and imaging and ADMET testing products. Clontech...
...1999 for $200 million in cash. For the fiscal year ending Sept. 30, BDX expects Clontech...
BioCentury | Oct 4, 2004
Company News

Becton Dickinson to sell Clontech

...BDX's BD Biosciences subsidiary plans to sell its Clontech division in order to focus on cell...
...order to focus on cell analysis products, discovery labware, and imaging and ADMET testing products. Clontech...
...1999 for $200 million in cash. For the fiscal year ending Sept. 30, BDX expects Clontech...
BioCentury | Jun 14, 2004
Company News

Perlegen management update

...Singleton as VP of engineering and informatics; and William Sims as CFO, formerly CFO of Clontech Laboratories Inc. WIR...
Items per page:
1 - 10 of 45
BioCentury | Jan 25, 2016
Company News

Takara Bio sales and marketing update

...Takara’s Clontech Laboratories Inc. subsidiary launched the Guide-it CRISPR/ Cas9 Gesicle production system for the delivery of Cas9...
BioCentury | Nov 24, 2014
Company News

Broad Institute, Takara Bio deal

...Takara’s Clontech Laboratories Inc. subsidiary received non-exclusive rights to Broad’s IP related to CRISPR/ Cas9 gene editing system...
BioCentury | Apr 25, 2011
Company News

Ariad, Takara Bio sales and marketing update

...Takara Bio's Clontech Laboratories Inc. subsidiary launched iDimerize inducible dimerization systems in the U.S. for research use only...
...cell and gene therapy. The systems use Ariad's Argent cell signaling regulation technology, for which Clontech...
BioCentury | Aug 2, 2010
Company News

Gentel sales and marketing update

...The kit combine Gentel's APiX chromogenic detection platform and Antibody 380 array technology from the Clontech Laboratories Inc....
BioCentury | Aug 2, 2010
Company News

Takara Bio, TET Systems GmbH & Co. KG deal

...Takara's Clontech Laboratories Inc. subsidiary and TET added the Tet-On 3G System to a 1996 deal, granting Clontech...
...system is a research tool designed to control gene expression in vitro and in vivo. Clontech...
BioCentury | Jun 4, 2007
Company News

Invitrogen, Takara Bio supply/service news

...Takara's Clontech Laboratories Inc. subsidiary and IVGN settled all litigation related to IVGN's patents covering RNase H minus...
...covering RNase H minus reverse transcriptase. The RNA-dependent DNA polymerase is used in cDNA synthesis. Clontech...
...last of the patents expires in 2012. Further terms were not disclosed. IVGN originally accused Clontech...
BioCentury | Jul 31, 2006
Company News

Takara Bio, Bayer sales and marketing update

...BAY's Bayer Healthcare unit granted Takara's Clontech division an exclusive worldwide license to sell Ready-to-Glow secreted...
BioCentury | Oct 11, 2004
Company News

Becton Dickinson supply/service news

...BDX plans to sell its Clontech division in order to focus on cell analysis products, discovery...
...order to focus on cell analysis products, discovery labware, and imaging and ADMET testing products. Clontech...
...1999 for $200 million in cash. For the fiscal year ending Sept. 30, BDX expects Clontech...
BioCentury | Oct 4, 2004
Company News

Becton Dickinson to sell Clontech

...BDX's BD Biosciences subsidiary plans to sell its Clontech division in order to focus on cell...
...order to focus on cell analysis products, discovery labware, and imaging and ADMET testing products. Clontech...
...1999 for $200 million in cash. For the fiscal year ending Sept. 30, BDX expects Clontech...
BioCentury | Jun 14, 2004
Company News

Perlegen management update

...Singleton as VP of engineering and informatics; and William Sims as CFO, formerly CFO of Clontech Laboratories Inc. WIR...
Items per page:
1 - 10 of 45